Skip to content
Sickle Cell Association of the National Capital Area, Inc.

Sickle Cell Association of the National Capital Area, Inc.

SCANCA, Inc.

  • HOME
  • LEARN
    • About Sickle Cell
    • Types of Sickle Cell Disease
    • Sickle Cell Trait
    • Complications of Sickle Cell Disease
    • Treatment
    • Promising Treatment Developments
  • CARE
    • Infants & Children
    • Adolescents
    • Women
    • Men
    • Adults
    • Families and Friends
  • Research
  • SUPPORT
    • Outreach
    • Research
    • Scholarship
    • Summer Camp
    • SCANCA Newsletter
  • Membership
    • 1 Year Membership Dues
    • 1 Year Organizations / Corporations Membership Dues
    • Scholarship Donation
  • Donate Now
  • ABOUT US

Author: ESB Technology

Video: New Treatment for Sickle Cell Brings Hope and a Cure to Chicago Area Patients

February 2, 2017 ESB Technology Video

  Source Newsroom: University of Illinois at Chicago Newswise — Two brothers have been cured of their sickle cell disease[…]

Read more

First Patient in Phase 3 Hope Study in Sickle Cell

February 1, 2017 ESB Technology News

Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease SOUTH SAN Francisco,[…]

Read more

Video: Sickle Cell Anemia: A Patient’s Journey

February 1, 2017 ESB Technology Video

As a young child, Alexandria, now age 17, endured near-constant feelings of exhaustion and general sickness, which turned into severe[…]

Read more

Posts navigation

«Previous Posts 1 … 3 4 5

Virtual Sickle Cell Support Group

Sickle Cell Association of the National Capital Area, INC.
P.O. Box 41479
Washington, DC 20018-08792
(202) 271-5733
email@scancainc.org
Copyright 2017